Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Beáta-Mária Benkő, Dimitrios A. Lamprou, Anna Sebestyén, Romána Zelkó & István Sebe. (2023) Clinical, pharmacological, and formulation evaluation of disulfiram in the treatment of glioblastoma - a systematic literature review. Expert Opinion on Drug Delivery 20:4, pages 541-557.
Read now
Read now
Articles from other publishers (9)
Rocío A. Conforti, María B. Delsouc, Edith Zorychta, Carlos M. Telleria & Marilina Casais. (2023) Copper in Gynecological Diseases. International Journal of Molecular Sciences 24:24, pages 17578.
Crossref
Crossref
Lydia W. Njenga, Simon N. Mbugua, Ruth A. Odhiambo & Martin O. Onani. (2023) Addressing the gaps in homeostatic mechanisms of copper and copper dithiocarbamate complexes in cancer therapy: a shift from classical platinum-drug mechanisms. Dalton Transactions 52:18, pages 5823-5847.
Crossref
Crossref
Feilong Sun, Hongzhi Wang, Jinfu Nie & Bo Hong. (2022) Repurposing Disulfiram as a Chemo-Therapeutic Sensitizer: Molecular Targets and
Mechanisms. Anti-Cancer Agents in Medicinal Chemistry 22:17, pages 2920-2926.
Crossref
Crossref
Marina Solovieva, Yuri Shatalin, Irina Odinokova, Olga Krestinina, Yulia Baburina, Artem Mishukov, Yana Lomovskaya, Liubov Pavlik, Irina Mikheeva, Ekhson Holmuhamedov & Vladimir Akatov. (2022) Disulfiram oxy-derivatives induce entosis or paraptosis-like death in breast cancer MCF-7 cells depending on the duration of treatment. Biochimica et Biophysica Acta (BBA) - General Subjects 1866:9, pages 130184.
Crossref
Crossref
Juliana Almeida-Silva, Diego Silva Menezes, Juan Mateus Pereira Fernandes, Márcio Cerqueira Almeida, Deyvison Rhuan Vasco-dos-Santos, Roberto Magalhães Saraiva, Alessandra Lifsitch Viçosa, Sandra Aurora Chavez Perez, Sônia Gumes Andrade, Ana Márcia Suarez-Fontes & Marcos André Vannier-Santos. (2022) The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Marcos André Vannier-Santos, Ana Márcia Suarez-Fontes, Juliana Almeida-Silva, Alessandra Lifsitch Viçosa, Sandra Aurora Chavez Perez, Alejandro Marcel Hasslocher-Moreno, Gabriel Parreiras Estolano da Silveira, Luciana Fernandes Portela & Roberto Magalhães Saraiva. 2022. Chagas Disease - From Cellular and Molecular Aspects of Trypanosoma cruzi-Host Interactions to the Clinical Intervention. Chagas Disease - From Cellular and Molecular Aspects of Trypanosoma cruzi-Host Interactions to the Clinical Intervention.
Richard E. Kast, Alex Alfieri, Hazem I. Assi, Terry C. Burns, Ashraf M. Elyamany, Maria Gonzalez-Cao, Georg Karpel-Massler, Christine Marosi, Michael E. Salacz, Iacopo Sardi, Pieter Van Vlierberghe, Mohamed S. Zaghloul & Marc-Eric Halatsch. (2022) MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen. Cancers 14:10, pages 2563.
Crossref
Crossref
Kosta J. Popović, Dušica J. Popović, Dejan Miljković, Jovan K. Popović, Dušan Lalošević, Mihalj Poša & Ivan Čapo. (2021) Disulfiram and metformin combination anticancer effect reversible partly by antioxidant nitroglycerin and completely by NF-κB activator mebendazole in hamster fibrosarcoma. Biomedicine & Pharmacotherapy 143, pages 112168.
Crossref
Crossref
Maria V. Babak & Dohyun Ahn. (2021) Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance. Biomedicines 9:8, pages 852.
Crossref
Crossref